Diaceutics (LON:DXRX) Announces Quarterly Earnings Results

by · The Markets Daily

Diaceutics (LON:DXRX – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported GBX (3.27) earnings per share for the quarter, Digital Look Earnings reports. Diaceutics had a net margin of 0.25% and a return on equity of 0.25%.

Diaceutics Stock Performance

LON:DXRX opened at GBX 181.71 on Tuesday. The firm has a market cap of £154.20 million, a price-to-earnings ratio of 1,651.91 and a beta of 0.88. The firm’s fifty day moving average price is GBX 145.09 and its 200 day moving average price is GBX 150.64. Diaceutics has a 1-year low of GBX 125 and a 1-year high of GBX 182.91. The company has a debt-to-equity ratio of 2.85, a current ratio of 3.43 and a quick ratio of 9.92.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group reaffirmed a “buy” rating and issued a GBX 215 target price on shares of Diaceutics in a research report on Tuesday. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of GBX 215.

Get Our Latest Stock Report on Diaceutics

About Diaceutics

(Get Free Report)

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.

Featured Stories